The latest closing stock price for Intellia Therapeutics as of January 21, 2025 is 9.94.
An investor who bought $1,000 worth of Intellia Therapeutics stock at the IPO in 2016 would have $-550 today, roughly -1 times their original investment - a -8.50% compound annual growth rate over 9 years.
The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021.
The Intellia Therapeutics 52-week high stock price is 34.87, which is 250.8% above the current share price.
The Intellia Therapeutics 52-week low stock price is 9.25, which is 6.9% below the current share price.
The average Intellia Therapeutics stock price for the last 52 weeks is 21.60.
An investor who bought $1,000 worth of Intellia Therapeutics stock at the IPO in 2016 would have $-550 today, roughly -1 times their original investment - a -8.50% compound annual growth rate over 9 years.
The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021.
The Intellia Therapeutics 52-week high stock price is 34.87, which is 250.8% above the current share price.
The Intellia Therapeutics 52-week low stock price is 9.25, which is 6.9% below the current share price.
The average Intellia Therapeutics stock price for the last 52 weeks is 21.60.